JP MORGAN/CALL/BECTON DICKINSON AND CO./260/0.1/17.01.25 Share Price

Warrant

DE000JL1KNU3

Market Closed - Börse Stuttgart 08:20:38 31/05/2024 BST
1.18 EUR +16.83% Intraday chart for JP MORGAN/CALL/BECTON DICKINSON AND CO./260/0.1/17.01.25
Current month-32.95%
1 month-32.95%
Date Price Change
31/05/24 1.18 +16.83%
30/05/24 1.01 -10.62%
29/05/24 1.13 -13.74%
28/05/24 1.31 +8.26%
27/05/24 1.21 -11.68%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 08:20 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JL1KNU
ISINDE000JL1KNU3
Date issued 05/04/2023
Strike 260 $
Maturity 17/01/2025 (230 Days)
Parity 10 : 1
Emission price 2.88
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.17
Lowest since issue 1.01
Spread 0.15
Spread %9.74%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
232 USD
Average target price
278.7 USD
Spread / Average Target
+20.14%
Consensus